What is Zacks Research’s Forecast for NTLA FY2025 Earnings?
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Investment analysts at Zacks Research increased their FY2025 EPS estimates for shares of Intellia Therapeutics in a report issued on Tuesday, April 22nd. Zacks Research analyst R. Department now anticipates that the company will earn ($5.38) per share for the year, up from their previous forecast of […]
Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) – Investment analysts at Zacks Research increased their FY2025 EPS estimates for shares of Intellia Therapeutics in a report issued on Tuesday, April 22nd. Zacks Research analyst R. Department now anticipates that the company will earn ($5.38) per share for the year, up from their previous forecast of […]
